Ewing Sarcoma/Primitive Neuroectodermal Tumor of the Chest Wall: Impact of Initial Versus Delayed Resection on Tumor Margins, Survival, and Use of Radiation Therapy

Annals of Surgery

Volumn 238, Issue 4, 2003, Pages 563-568

  Shamberger, Robert C ^a   LaQuaglia, Michael P ^b   Gebhardt, Mark C ^a   Neff, James R ^c   Tarbell, Nancy J ^d   Marcus, Karen C ^a   Sailer, Scott L ^e   Womer, Richard B ^f   Miser, James S ^g   Dickman, Paul S ^h   Perlman, Elizabeth J ⁱ   Devidas, Meenakshi ^j   Linda, Stephen B ^j   Krailo, Mark D ^k   Grier, Holcombe E ^a   Granowetter, Linda ^l   Andrassy, Richard J ^m   Brennan, Murray F ^m   Vasconez, Luis O ^m   Weber, Thomas R ^m  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF PENNSYLVANIA   (United States)

^g Division of Pediatrics   (United States)

^h CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

ⁱ NORTHWESTERN UNIVERSITY   (United States)

^j University of Florida ^*  (United States)

^k UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^l Columbia Univ Coll of Phys/Surgs ^*  (United States)

^m Children's Hospital ^*

more..

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DACTINOMYCIN; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; VINCRISTINE;

ADULT; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL PROTOCOL; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EWING SARCOMA; FOLLOW UP; HUMAN; HUMAN TISSUE; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; NEUROECTODERM TUMOR; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL; SURVIVAL RATE; THORAX WALL TUMOR; ADJUVANT CHEMOTHERAPY; ARTICLE; BONE TUMOR; COMPARATIVE STUDY; DISEASE FREE SURVIVAL; MORTALITY; RIB; TIME;

ADULT; BONE NEOPLASMS; CHEMOTHERAPY, ADJUVANT; DISEASE-FREE SURVIVAL; HUMANS; NEUROECTODERMAL TUMORS, PRIMITIVE; RANDOMIZED CONTROLLED TRIALS; RIBS; SARCOMA, EWING'S; TIME FACTORS;

EID: 10744232124     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (16)

1. Strong LC, Herson J, Osborne BM, et al. Risk of radiation-related subsequent malignant tumors in survivors of Ewing's sarcoma. J Natl Cancer Inst. 1979;62:1401-1406.
2. Tucker MA, D'Angio GJ, Boice JD Jr, et al. Bone sarcomas linked to radiotherapy and chemotherapy in children. N Engl J Med. 1987;317:588-593.
3. Kuttesch JF Jr, Wexler LH, Marcus RB, et al. Second malignancies after Ewing's sarcoma: radiation dose-dependency of secondary sarcomas. J CIin Oncol. 1996;14:2818-2825.
4. Paulussen M, Ahrens S, Lehnert M, et al. Second malignancies after Ewing tumor treatment in 690 patients from a cooperative German/Austrian/Dutch study. Ann Oncol. 2001;12:1619-1630.
5. Shamberger RC, Laquaglia MP, Krailo MD, et al. Ewing sarcoma of the rib: results of an intergroup study with analysis of outcome by timing of resection. J Thorac Cardiovasc Surg. 2000;119:1154-1161.
6. Grier HE, Krailo MD, Tarbell NJ, et al. Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone. N Engl J Med. 2003;348:694-701.
7. Granowetter L, Womer R, Devidas M, et al. Comparison of dose intensified and standard dose chemotherapy for the treatment of non-metastatic Ewing's sarcoma (ES) and primitive neuroectodermal tumor (PNET) of bone and soft tissue: a Pediatric Oncology Group-Children's Cancer Group phase III trial. SIOP XXXIII meeting, Brisbane. Med Pediatr Oncol. 2001;37:172.
8. Peto R, Pike MC, Armitage P, et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer. 1977;35:1-39.
9. Lawless JF. Statistical Models and Methods for Lifetime Data. New York: John Wiley & Sons; 1982.
10. Horning SJ, Adhikari A, Rizk N, et al. Effect of treatment for Hodgkin's disease on pulmonary function: results of a prospective study. J Clin Oncol. 1994;12:297-305.
11. Marks LB. The pulmonary effects of thoracic irradiation. Oncology. 1994;8:89-106; discussion 100, 103-104.
12. Corn BW, Trock BJ, Goodman RL. Irradiation-related ischemic heart disease. J Clin Oncol. 1990;8:741-750.
13. Boivin JF, Hutchison GB, Lubin JH, et al. Coronary artery disease mortality in patients treated for Hodgkin's disease. Cancer. 1992;69:1241-1247.
14. Rao BN, Hayes FA, Thompson EI, et al. Chest wall resection for Ewing's sarcoma of the rib: an unnecessary procedure. Ann Thorac Surg. 1988;46:40-44.
15. Rao BN, Hayes FA, Thompson EI, et al. Chest wall resection for Ewing's sarcoma of the rib: an unnecessary procedure. 1988. Updated in 1995. Ann Thorac Surg. 1995;60:1454-1455.
16. Shamberger RC, Tarbell NJ, Perez-Atayde AR, et al. Malignant small round cell tumor (Ewing's-PNET) of the chest wall in children. JPediatr Surg. 1994;29:179-184; discussion 184-185.